Forte Biosciences (FBRX)

• Market cap: $310M
• 1 day: 6.36%
• 5 days: 21.15%
• 1 month: 70.81%
• 3 months: 106.94%
• 6 months: 99.92%
• Year to date: -2.06%
• 1 year: 25.89%
• 5 years: -97.53%
• 10 years: -99.47%
• Sector: Healthcare
• Industry: Biotechnology

About: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Employees: 16